Skip to content

Telerehabilitation for Post COVID-19 Condition

A Pilot Study to Evaluate the Implantation and the Impact of a Hybrid Telerehabilitation Program Based on Cardiopulmonary Rehabilitation Principles for People With Post-COVID Affection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05973136
Acronym
Telecovie
Enrollment
7
Registered
2023-08-02
Start date
2022-04-01
Completion date
2022-08-08
Last updated
2023-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Fatigue Syndrome, Long COVID

Keywords

cardiorespiratory, exercise, virtual rehabilitation, post COVID-19 syndrome, fatigue, physiotherapy, post-COVID affection, post-COVID condition

Brief summary

Telerehabilitation is a great alternative to offering care during a global pandemic. 85% of patients with COVID-19 report persistent symptoms up to 8 months after the infection. There are no clear recommendations for post-covid rehabilitation. The aims of the study are (1) to test the logistic aspect of implanting a hybrid rehabilitation program and (2) to evaluate the acceptability and the potential impact of the program on treating patients with functional limitations and persistent fatigue symptoms. It's a pre and post-study without a control group.

Detailed description

Telerehabilitation is a great alternative to offering care during a global pandemic. 85% of patients with COVID-19 report persistent symptoms up to 8 months after the infection. There are no clear recommendations for post-covid rehabilitation. The aims of the study are (1) to test the logistic aspect of implanting a hybrid rehabilitation program and (2) to evaluate the acceptability and the potential impact of the program on treating patients with functional limitations and persistent fatigue symptoms. It's a pre and post-study without a control group. The intervention will be based on cardiopulmonary rehabilitation principles and will be administered for 12 weeks. Fatigue, post-exertional malaise, and functional/exercise capacities will be evaluated.

Interventions

OTHERTelerehabilitation program based on cardiorespiratory principles

The intervention consists of a hybrid program. The participant will receive rehabilitation sessions in presence (aerobic component of the intervention based on maximal oxygen uptake measured before intervention by means on a ergospirometric test) and at home via a telerehabilitation platform. The length of the intervention is 12 weeks. For the in-presence sessions, they are going to be 75 minutes, 2x/week. For the at-distance sessions, they are going to be 45 minutes, 1x/week in groups of 3 to 4 participants. The intervention will consist of a warm-up, endurance, postural, and strengthening exercises, cool down and respiratory exercises. An exercise book with final recommendations is provided to the participants at the end of the intervention.

Sponsors

Hotel Dieu Hospital
CollaboratorOTHER
Université de Sherbrooke
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The study design is a pre-post without a control group

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Living in the community * Living near Sherbrooke (\<50km) * Having a diagnostic of COVID-19 confirmed (PCR) and post-COVID syndrome (according to the World Health Organization criteria) * Being aged between 25 and 65 years old * Having access to internet at home * Living with a family member/caregiver or having a telephone or a medical alert system (in case of emergency) * Reporting persistent fatigue symptoms according to the Fatigue Severity Scale (FSS) (score≥4/7) * Reporting functional limitations according to the Post-COVID-19 Functional Status scale (PCFS (score ≥2/4); * Being able to give free and informed consent (adequate understanding of the study protocol); * Agreeing to perform a pulmonary function test, an exercise stress test, and an ergospirometric exercise test (adequate understanding of steps and procedures); * Having a low exercise capacity and moderate-to-severe cardiovascular risk \<7 metabolic equivalent of a task (MET) or ≤9 if significant reduction of self-reported exercise tolerance according to the stress test performed on a treadmill - Cornell protocol); * Having no other potential explanatory causes for fatigue or reduced exercise capacity according to medical evaluation

Exclusion criteria

* Cognitive impairment: Mini-Mental State Examination (MMSE) ≤24/30 * Inability to perform or understand study procedures * Medical contraindication

Design outcomes

Primary

MeasureTime frameDescription
The feasibility of the program12 weeksThis will be evaluated by % of participants that accept to participate in the study (recruitment rate), % who completed the intervention (retention rate) and % completed session/anticipated session (adherence). The security of the program will be evaluated by the number of falls or near fall. Technical difficulty
Acceptability12 weeksThe satisfaction of the participants will be evaluated with a questionnaire (14 questions). The questionnaire will assess patients' satisfaction with the professional, the services and the organization - Telemedicine Satisfaction. Qualitative open-ended questions will be used to determine appreciation and challenges encountered.
Fatigue and post-exercise malaise12 weeksThis will be evaluated with the Fatigue severity scare and De Paul Symptom Questionnaire.

Secondary

MeasureTime frameDescription
Heart rate variability (resting)12 weeksMeasured with the POLAR H10
Lower-limb endurance (estimated)12 weeks1-minute sit-to-stand test
Functional capacity12 weeksStrength, assistance with walking, rising from a chair, climbing stairs, and falls questionnaire (SARC-F)
Exercise capacity12 weeks6-minute walk test

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026